INTRODUCTION
============

Recently, fat cells, especially visceral fat and central body fat (BF), are known not only as a simple energy depository tissue, but also as an active endocrine organ releasing a variety of active molecules known as adipokines ([@b4-jer-13-4-472]; [@b8-jer-13-4-472]; [@b11-jer-13-4-472]). Excess visceral fat cell releases more inflammatory cytokines such as C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-α) and elevates the level of oxidative stress, leading to insulin resistance in skeletal muscles which may induce diabetes, ([@b3-jer-13-4-472]). Furthermore, central obesity is associated with a decreased production of adiponectin, antidiabetic, antiatherosclerotic and anti-inflammatory molecule, which causes chronic disease ([@b16-jer-13-4-472]). Thus, the inflammatory pathway is a potential therapeutic target for lifestyle interventions designed for the obese population to reduce disease and disability ([@b24-jer-13-4-472]).

Chronic aerobic exercise has been considered as one of the effective and preventive countermeasure to chronic diseases. Results of previous studies indicated that regular aerobic exercise improves many components of the cardiovascular risk factor as well as insulin sensitivity ([@b4-jer-13-4-472]; [@b6-jer-13-4-472]; [@b13-jer-13-4-472]; [@b18-jer-13-4-472]) by enhancing a variety of metabolic abnormalities and decreasing cardiovascular risk factors. Therefore, it is plausible that regular aerobic exercise may improve the inflammatory profile independently from weight loss. Previous studies found reductions in pro-inflammatory cytokines ([@b1-jer-13-4-472]; [@b2-jer-13-4-472]; [@b9-jer-13-4-472]; [@b10-jer-13-4-472]; [@b17-jer-13-4-472]; [@b23-jer-13-4-472]), indicating that long-term exercise training may reduce chronic low-level inflammation in overweight and obese population. However, the more recent studies failed to confirm the effects of exercise on inflammatory cytokines ([@b4-jer-13-4-472]; [@b13-jer-13-4-472]; [@b15-jer-13-4-472]), possibly due to not isolating the effects of exercise training from weight loss. In addition, the mechanism which links exercise training to these inflammatory markers is not fully understood yet.

With given information of the relation between obesity and cardiovascular risk factors, insulin resistance, and inflammation, it is important to understand whether systemic inflammation can be in part explained by the physiologic benefits of exercise and whether exercise can be used as a potential therapeutic intervention for overweight and obese individuals. Therefore, we designed a short-term exercise training intervention to investigate effects of exercise training on inflammatory biomarkers in the absence of weight loss and fat loss.

MATERIALS AND METHODS
=====================

Participants
------------

Twenty-seven overweight or obese (body mass index \[BMI\] \>25.0 kg/m^2^) men (n=13) and women (n=14), ages between 18 and 65 years, participated in the study. All participants were physically inactive; did not have any known chronic disease; did not take medication that would alter metabolic, cardiovascular, or immune function; and had no musculoskeletal limitations. This study was approved by the Institutional Review Board and the participants provided written informed consent and the medical history forms prior to performing any study protocols. The participants maintained a normal dietary regimen and refrained from any forms of aerobic or anaerobic physical activity other than the exercise treatment throughout the study period.

Study design
------------

### Exercise intervention

During the initial visit, the participants were randomly assigned to either exercise (EX; n=15) or control (CON; n=12) group and anthropometric and physiological variables at baseline were then measured ([Table 1](#t1-jer-13-4-472){ref-type="table"}). Additionally, the participants that were assigned to the EX group conducted a treadmill exercise test to determine the appropriate exercise intensity (70% of age-predicted maximal heart rate \[HRmax\], 0.7 × \[220 -- age\]). During the initial treadmill exercise testing, the participants were allowed to choose their own desirable and comfortable walking speed, which was maintained throughout the testing. However, the grade (%) was adjusted every 2 min until the participants reached their target exercise intensity (70% of HRmax). Once the participants reached their target exercise intensity, the speed and grade were recorded, and the testing was terminated. As for the exercise intervention, the participants in the EX group performed walking exercise on the treadmill at predetermined exercise intensity (70% HRmax) for 60 min, 3 days a week for 4 weeks. During each exercise session, the participants'heart rate was monitored using the Polar heart rate monitor (Polar Electro Inc., Lake Success, NY, USA) and recorded every 10 min to ensure their target exercise intensity. All exercise sessions were supervised by research assistants. The participants in the CON group did not perform any physical activity throughout the study period.

### Measurement of body composition

Body composition including muscle mass, fat mass, and % BF were measured using a bioelectrical impedance analyzer (BIA-101A, RJL Systems, Clinton Township, MI, USA). The participants refrained from physical activity, sauna, or alcohol consumption within 12 hr prior to the measurement of body composition. During the measurement, the participants lay supine on the floor with arms away from the body with no shoes, socks, or any jewelry, and electrodes were placed on a hand and foot as instructed by the manufacture's procedure. The participants remained lying on the floor until the completion of the test and then resistance and reactance were recorded, which were later used to estimate muscle mass, fat mass, and % BF using Body Composition software (BC 2.1, RJL Systems, Clinton Township, MI, USA).

### Blood sample collection

Five milliliters of overnight fasting (10--12 hr) blood samples were collected at pre- and poststudy. After 10 min of resting in a chair, venous blood from the antecubital vein was collected into a serum tube, remained at room temperature for 20 min to be clotted, and then was centrifuged (1,000 g) at 4°C for 20 min to separate serum. Serum samples were allocated into 1.5 mL tubes and immediately frozen at −80°C for the further analyses.

### Blood analyses

Serum samples in duplicate were assayed via the enzyme-linked immunosorbent assay (Boster Biological Technology Co., Ltd., Pleasanton, CA, USA) to measure blood adiponectin, TNF-α, and CRP concentrations. Optical density was measured by the microplate reader (EL 808, BioTek Co, Winooski, VT, USA). The mean intra-assay coefficient of variabilities (CVs) were 6.9%, 4.3%, and 5.3% and inter-assay CVs were 8.2%, 6.7%, and 7.8% for adiponectin, TNF-α, and CRP, respectively.

Data analysis
-------------

The sample size was calculated by G\*Power 3.1.0 software, given an alpha level at 0.05, an effect size of 0.40, and power at 0.80. The appropriate sample size was estimated to be 21 participants for the current study. All statistical analyses were conducted using Sigmaplot 13 (Systat Software, Inc., San Jose, CA, USA). Two-way analysis of variance with repeated measures was used to analyze changes in BMI, body composition, and inflammatory cytokines. *Post hoc* tests were performed using Tukey *post hoc* test and statistical significance was set at *P*\<0.05.

RESULTS
=======

Physical characteristics and body composition at baseline (Pre) and after the 4 weeks of moderate intensity walking exercise (Post) are shown up in [Table 1](#t1-jer-13-4-472){ref-type="table"}. There were no significant differences found between EX and CON groups at Pre. Body weight, BMI, and % BF were unaltered following the 4 weeks of moderate intensity walking exercise.

Changes in inflammatory cytokines are found in [Table 2](#t2-jer-13-4-472){ref-type="table"}. Although there was a noticeable decrease in CRP following the 4 weeks of moderate intensity walking exercise, it was not statistically significant (EX: mean±standard deviation \[SD\], Pre 6.38±2.33 μg/mL, Post 5.11±1.78 μg/mL, *P*=0.062 vs. CON: Pre 6.44±1.77 μg/mL, Post 6.54±1.88 μg/mL, *P*=0.76). There was no significant group×time interaction found in the level of adiponectin (EX: mean±SD, Pre 7.1±1.3 μg/mL, Post 7.2±1.3 μg/mL, *P*=0.87 vs. CON: Pre 9.8±1.5 μg/mL, Post 9.9±1.5 μg/mL, *P*=0.83) although CON showered higher value as compared to EX (group effect, *P*=0.040). However, there was a significant group×time interaction ([Fig. 1](#f1-jer-13-4-472){ref-type="fig"}) for TNF-α and the *post hoc* test revealed that TNF-α significantly decreased only in EX (EX: mean±SD, Pre 55.18±6.57 pg/mL, Post 50.31±6.22, *P*=0.018 vs. CON: Pre 55.5±5.88, Post 58.19±6.48, *P*=0.25). EX Post is also significantly lower as compared to CON Post (*P*=0.0074).

DISCUSSION
==========

The current study investigated the effects of a 4-week moderate intensity walking exercise on levels of pro-/anti-inflammatory cytokines in overweight or obese individuals in the absence of weight loss. The 4-week exercise training resulted in no changes in fat mass, CRP, or adiponectin, whereas TNF-α was significantly reduced.

Physical inactivity and obesity have been considered as independent risk factors for cardiovascular diseases and metabolic syndrome, which may contribute to an increase in circulating inflammatory markers ([@b1-jer-13-4-472]; [@b2-jer-13-4-472]; [@b4-jer-13-4-472]; [@b6-jer-13-4-472]; [@b8-jer-13-4-472]; [@b11-jer-13-4-472]). However, the effects of regular exercise on inflammation are inconclusive due to lack of evidence.

[@b24-jer-13-4-472] found that the diet plus exercise intervention decreased CRP and TNF-α, while the diet only group failed to show the same result although the similar amount of reduction in fat mass was observed. The result corresponded to other previous research ([@b1-jer-13-4-472]; [@b2-jer-13-4-472]; [@b17-jer-13-4-472]; [@b22-jer-13-4-472]; [@b23-jer-13-4-472]). Other studies found that the levels of pro-inflammatory cytokines are in an inverse relationship with aerobic fitness ([@b9-jer-13-4-472]; [@b14-jer-13-4-472]); however, the same effect has not uniformly been seen in all intervention studies.

[@b5-jer-13-4-472] reported that the reductions of inflammatory cytokines are not achieved by exercise intervention but are directly associated with loss of fat mass, suggesting that significant reductions of inflammatory cytokines can be obtained with more than 5% loss of fat mass. It was correspondent to [@b19-jer-13-4-472] and [@b15-jer-13-4-472], which added that changes in adiponectin is also associated with weight loss instead of improvement in fitness and concluded that regular exercise does not change the levels of inflammatory cytokines. In addition, most of the studies that reported significant changes in inflammatory cytokines by exercise training found weight loss; therefore, it is not clear whether changes in inflammatory cytokines following exercise training is caused by physiological benefits of exercise training or by weight loss accompanied to exercise.

In the present study, CRP and adiponectin did not change following the 4 weeks of moderate intensity exercise training. It is probable that changes in CRP and adiponectin may require a certain duration of exercise training or at least moderate amount of weight loss as shown in other studies ([@b7-jer-13-4-472]; [@b12-jer-13-4-472]; [@b15-jer-13-4-472]; [@b20-jer-13-4-472]; [@b21-jer-13-4-472]).

In conclusion, the present study suggests that TNF-α can be lowered following the 4 weeks of moderate intensity exercise training in overweighed and obese individuals without a significant reduction in weight or fat mass, indicating physical activity independently from a change in fat mass may affect the level of inflammation. The present study also confirmed the previous studies suggesting that longer period of training may be required to induce a significant change in CRP or adiponectin. It is recommended that additional evidence be sought to elucidate the independent role of aerobic exercise training for chronic inflammation in overweight and obese individuals.
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![A group by time interaction showing changes in tumor necrosis factor-alpha (TNF-α) Values are presented as mean±standard deviation. EX, exercise group; CON, control group. \**P*=0.018.](jer-13-4-472f1){#f1-jer-13-4-472}

###### 

Changes in anthropometric characteristics and body composition

  Variable        EX (n=15)     CON (n=12)                  
  --------------- ------------- ------------- ------------- -------------
  Height (cm)     165.7±10.3    \-            171.1±7.7     \-
                                                            
  Weight (kg)     90.33±23.05   90.21±22.97   94.82±12.53   94.81±12.67
                                                            
  BMI (kg/m^2^)   33.24±5.67    32.91±5.73    32.54±5.28    32.58±5.23
                                                            
  Body fat (%)    35.42±8.91    34.62±9.12    34.50±9.99    35.61±9.82

Values are presented as mean±standard deviation.

EX, exercise group; CON, control group; BMI, body mass index.

###### 

Changes in inflammatory cytokines

  Variable                     EX (n=15)    CON (n=12)                                                            
  ---------------------------- ------------ --------------------------------------------------------- ----------- ------------
  C-reactive protein (μg/mL)   6.38±2.33    5.11±1.78                                                 6.44±1.77   6.54±1.88
                                                                                                                  
  Adiponectin (μg/mL)          7.1±1.3      7.2±1.3                                                   9.8±1.5     9.9±1.5
                                                                                                                  
  TNF-α (pg/mL)                55.18±6.57   50.31±6.22[\*](#tfn5-jer-13-4-472){ref-type="table-fn"}   55.5±5.88   58.19±6.48

Values are presented as mean±standard deviation.

EX, exercise group; CON, control group; TNF-α, tumor necrosis factor-alpha.

Significantly different from Pre (*P*=0.018), significantly different from CON Post (*P*=0.0074).
